首页 > 最新文献

Korean journal of hepato-biliary-pancreatic surgery最新文献

英文 中文
Tailored long-term immunosuppressive regimen for adult liver transplant recipients with hepatocellular carcinoma. 针对肝癌成人肝移植受者量身定制的长期免疫抑制方案。
Pub Date : 2014-05-01 Epub Date: 2014-05-31 DOI: 10.14701/kjhbps.2014.18.2.48
Sung-Hwa Kang, Shin Hwang, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Gil-Chun Park, Bo-Hyun Jung, Young-In Yoon, Sung-Gyu Lee

Backgrounds/aims: There are few guidelines for tailored immunosuppressive regimens for liver transplantation (LT) recipients with hepatocellular carcinoma (HCC). To establish long-term immunosuppressive regimens suitable for Korean adult LT recipients, we analyzed those that were currently in use at a single high-volume institution.

Methods: This cross-sectional study comprises three parts including review of the immunosuppressive regimens used to manage 2,147 adult LT outpatients, review of LT recipients who were diagnosed of HCC at LT, and review of LT recipients who suffered from HCC recurrence.

Results: In 1,000 adult LT recipients who were living more than 5 years with no adverse events, 916 received a calcineurin inhibitor (CNI)-based therapy (CNI only in 520; CNI with mycophenolate mofetil [MMF] in 396) and 84 were receiving an MMF-based therapy (MMF only in 45; MMF with minimal CNI in 39). Tacrolimus was preferred over cyclosporine for both monotherapy and combination therapy along the passage of posttransplant period. There was no difference in selection of immunosuppressants, target blood concentration, and rate of combination therapy between LT recipients with and without HCC, except for the first 1 year. Sirolimus-based regimens were applied in 21 patients who showed HCC recurrence. Sorafenib was often used after conversion to sirolimus.

Conclusions: Tailored immunosuppressive regimen covering the long-term posttransplant period should be established after consideration of individualized patient profiles including HCC.

背景/目的:对于肝移植(LT)肝细胞癌(HCC)患者,目前很少有针对其量身定制的免疫抑制方案的指南。为了建立适合韩国成人肝移植受体的长期免疫抑制方案,我们分析了目前在一个大容量机构使用的方案。方法:本横断面研究包括三部分,包括对2147例成年肝移植门诊患者的免疫抑制方案的回顾,对在肝移植时被诊断为HCC的肝移植受体的回顾,以及对HCC复发的肝移植受体的回顾。结果:在1000名存活超过5年且无不良事件的成人肾移植受者中,916人接受了基于钙调磷酸酶抑制剂(CNI)的治疗(仅520人接受CNI治疗;396名CNI患者接受霉酚酸酯[MMF]治疗,84名患者接受基于MMF的治疗(45名患者接受MMF治疗;MMF与最小CNI在39)。他克莫司在移植后的单药治疗和联合治疗中优于环孢素。除了前1年,有和没有HCC的肝移植受体在免疫抑制剂的选择、靶血浓度和联合治疗率方面没有差异。以西罗莫司为基础的方案应用于21例HCC复发患者。索拉非尼常在转为西罗莫司后使用。结论:在考虑包括HCC在内的个体化患者情况后,应该建立覆盖移植后长期的量身定制的免疫抑制方案。
{"title":"Tailored long-term immunosuppressive regimen for adult liver transplant recipients with hepatocellular carcinoma.","authors":"Sung-Hwa Kang,&nbsp;Shin Hwang,&nbsp;Tae-Yong Ha,&nbsp;Gi-Won Song,&nbsp;Dong-Hwan Jung,&nbsp;Ki-Hun Kim,&nbsp;Chul-Soo Ahn,&nbsp;Deok-Bog Moon,&nbsp;Gil-Chun Park,&nbsp;Bo-Hyun Jung,&nbsp;Young-In Yoon,&nbsp;Sung-Gyu Lee","doi":"10.14701/kjhbps.2014.18.2.48","DOIUrl":"https://doi.org/10.14701/kjhbps.2014.18.2.48","url":null,"abstract":"<p><strong>Backgrounds/aims: </strong>There are few guidelines for tailored immunosuppressive regimens for liver transplantation (LT) recipients with hepatocellular carcinoma (HCC). To establish long-term immunosuppressive regimens suitable for Korean adult LT recipients, we analyzed those that were currently in use at a single high-volume institution.</p><p><strong>Methods: </strong>This cross-sectional study comprises three parts including review of the immunosuppressive regimens used to manage 2,147 adult LT outpatients, review of LT recipients who were diagnosed of HCC at LT, and review of LT recipients who suffered from HCC recurrence.</p><p><strong>Results: </strong>In 1,000 adult LT recipients who were living more than 5 years with no adverse events, 916 received a calcineurin inhibitor (CNI)-based therapy (CNI only in 520; CNI with mycophenolate mofetil [MMF] in 396) and 84 were receiving an MMF-based therapy (MMF only in 45; MMF with minimal CNI in 39). Tacrolimus was preferred over cyclosporine for both monotherapy and combination therapy along the passage of posttransplant period. There was no difference in selection of immunosuppressants, target blood concentration, and rate of combination therapy between LT recipients with and without HCC, except for the first 1 year. Sirolimus-based regimens were applied in 21 patients who showed HCC recurrence. Sorafenib was often used after conversion to sirolimus.</p><p><strong>Conclusions: </strong>Tailored immunosuppressive regimen covering the long-term posttransplant period should be established after consideration of individualized patient profiles including HCC.</p>","PeriodicalId":91136,"journal":{"name":"Korean journal of hepato-biliary-pancreatic surgery","volume":"18 2","pages":"48-51"},"PeriodicalIF":0.0,"publicationDate":"2014-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.14701/kjhbps.2014.18.2.48","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33887492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Assessment of right liver graft perfusion effectiveness between one and two-catheter infusion methods. 一导管与双导管右肝移植灌注效果的比较。
Pub Date : 2014-05-01 Epub Date: 2014-05-31 DOI: 10.14701/kjhbps.2014.18.2.43
Bo-Hyun Jung, Shin Hwang, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Gil-Chun Park, Sung-Hwa Kang, Young-In Yoon, Sung-Gyu Lee

Backgrounds/aims: Conventional graft perfusion method using one small-caliber catheter takes a relatively long time for right liver graft perfusion, thus some modification is needed. In this study, we intended to assess the effectiveness of right liver graft perfusion methods through comparison of different infusion catheters.

Methods: The study consisted of two parts including one bench experiment to obtain data of hydraulic infusion and one clinical trial of 40 cases on graft perfusion with one- versus two-catheter infusion methods. These two graft infusion methods were compared in terms of the perfusion time and washing-out efficiency.

Results: At bench experiment, the infusion flow rate and infusion pressure were 3.3 ml/sec and 1.9 cmH20 in one blood transfusion catheter group, and 11.7 ml/sec and 3.1 cmH20 in single transurethral resection of prostate irrigation catheter group, and 6.6 ml/sec and 2.0 cmH20 in two blood transfusion catheters group, respectively. In clinical trial with 40 right liver grafts, two-catheter group had a shorter graft portal perfusion time for the first 2 L of histidine-tryptophan-ketoglutarate (HTK) solution than the conventional one-catheter group (375±25 seconds vs. 662±34 seconds; p=0.001) and a lower rate of incomplete blood washing-out after the initial 2 L portal perfusion (40% vs. 85%; p=0.03).

Conclusions: The two-catheter infusion method appears to be more effective than the conventional one-catheter infusion method for right liver graft perfusion at the back table. Large size of right liver grafts seems to be its good indication.

背景/目的:采用一根小口径导管的传统移植物灌注方法,右肝移植物灌注时间较长,需要进行一些改进。在本研究中,我们打算通过比较不同输注导管来评估右肝移植灌注方法的有效性。方法:本研究分为两部分,一是获得液压输注数据的台架实验,二是40例移植物单导管输注与双导管输注对比的临床试验。比较两种移植物输注方式的灌注时间和冲洗效率。结果:在台架实验中,一根输尿管组的输注流速和输注压力分别为3.3 ml/sec和1.9 cmH20,单根经尿道前列腺灌洗导管组的输注流速和输注压力分别为11.7 ml/sec和3.1 cmH20,两根输注导管组的输注流速和压力分别为6.6 ml/sec和2.0 cmH20。在40例右肝移植的临床试验中,组氨酸-色氨酸-酮戊二酸(HTK)溶液的前2 L灌注时间,双导管组比常规单导管组短(375±25秒比662±34秒);p=0.001),初始2l门静脉灌注后不完全洗血率较低(40% vs. 85%;p = 0.03)。结论:对于右肝移植后台灌注,双导管输注比常规单导管输注更有效。大尺寸右肝移植似乎是其良好的适应证。
{"title":"Assessment of right liver graft perfusion effectiveness between one and two-catheter infusion methods.","authors":"Bo-Hyun Jung,&nbsp;Shin Hwang,&nbsp;Tae-Yong Ha,&nbsp;Gi-Won Song,&nbsp;Dong-Hwan Jung,&nbsp;Ki-Hun Kim,&nbsp;Chul-Soo Ahn,&nbsp;Deok-Bog Moon,&nbsp;Gil-Chun Park,&nbsp;Sung-Hwa Kang,&nbsp;Young-In Yoon,&nbsp;Sung-Gyu Lee","doi":"10.14701/kjhbps.2014.18.2.43","DOIUrl":"https://doi.org/10.14701/kjhbps.2014.18.2.43","url":null,"abstract":"<p><strong>Backgrounds/aims: </strong>Conventional graft perfusion method using one small-caliber catheter takes a relatively long time for right liver graft perfusion, thus some modification is needed. In this study, we intended to assess the effectiveness of right liver graft perfusion methods through comparison of different infusion catheters.</p><p><strong>Methods: </strong>The study consisted of two parts including one bench experiment to obtain data of hydraulic infusion and one clinical trial of 40 cases on graft perfusion with one- versus two-catheter infusion methods. These two graft infusion methods were compared in terms of the perfusion time and washing-out efficiency.</p><p><strong>Results: </strong>At bench experiment, the infusion flow rate and infusion pressure were 3.3 ml/sec and 1.9 cmH20 in one blood transfusion catheter group, and 11.7 ml/sec and 3.1 cmH20 in single transurethral resection of prostate irrigation catheter group, and 6.6 ml/sec and 2.0 cmH20 in two blood transfusion catheters group, respectively. In clinical trial with 40 right liver grafts, two-catheter group had a shorter graft portal perfusion time for the first 2 L of histidine-tryptophan-ketoglutarate (HTK) solution than the conventional one-catheter group (375±25 seconds vs. 662±34 seconds; p=0.001) and a lower rate of incomplete blood washing-out after the initial 2 L portal perfusion (40% vs. 85%; p=0.03).</p><p><strong>Conclusions: </strong>The two-catheter infusion method appears to be more effective than the conventional one-catheter infusion method for right liver graft perfusion at the back table. Large size of right liver grafts seems to be its good indication.</p>","PeriodicalId":91136,"journal":{"name":"Korean journal of hepato-biliary-pancreatic surgery","volume":"18 2","pages":"43-7"},"PeriodicalIF":0.0,"publicationDate":"2014-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.14701/kjhbps.2014.18.2.43","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33887491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A survey of attitudes to clinical practice guidelines in general and adherence of the Korea practical guidelines for management of gallbladder polyp: a survey among private clinicians in Korea. 对一般临床实践指南的态度调查和遵守韩国胆囊息肉管理实用指南:韩国私人临床医生的调查。
Pub Date : 2014-05-01 Epub Date: 2014-05-31 DOI: 10.14701/kjhbps.2014.18.2.52
Jooyeon Jeong, Jae Keun Kim, Joon Seong Park, Dong Sup Yoon

Backgrounds/aims: While clinical practice guidelines are effective tools for improving the quality of patient care and provide specific recommendations for daily practice, the usage of them have been often suboptimal. Therefore, evaluation of physician attitude to guidelines is an important initial step in improving guideline adherence levels. The aim of this study was to survey the attitude on general guidelines and adherence with the Korea Practical Guidelines for gallbladder (GB) polyp two year after their publication and distribution among Korean private clinicians.

Methods: To evaluate the survey, questionnaires were sent with a stamp on an addressed envelope to 3,256 private clinicians who were registered at the Seoul Medical Association in April, 2010. From the 3,256 questionnaires, 376 clinicians (11.5%) responded to the survey.

Results: A total of 91.0% responders agreed to the statement that general guidelines were useful tools for improving patient care and quality of care. One hundred one responders (26.9%) stated that they were aware of the Korea GB polyp guidelines while 73 physicians (72.3%) founded the guideline had changed their practice and user-friendly. Most of physicians (73.4%) agreed to practical procedures recommended by guidelines.

Conclusions: Korean primary physicians were generally positive to the practical guidelines, as propagation of the guideline among primary physicians may improve adherence to guideline and patients care for GB polyps.

背景/目的:虽然临床实践指南是提高患者护理质量的有效工具,并为日常实践提供具体建议,但它们的使用往往不是最佳的。因此,评估医生对指南的态度是提高指南依从性水平的重要的第一步。本研究的目的是调查对一般指南的态度和遵守韩国实用指南胆囊息肉(GB)出版后两年的韩国私人临床医生分发。方法:为评估调查结果,于2010年4月向在首尔医学协会注册的3256名私人临床医生邮寄附有邮票的调查问卷。在3256份问卷中,376名临床医生(11.5%)回应了调查。结果:共有91.0%的应答者同意一般指南是改善患者护理和护理质量的有用工具。101名应答者(26.9%)表示他们知道韩国GB息肉指南,而73名医生(72.3%)认为该指南改变了他们的做法并便于使用。大多数医生(73.4%)同意指南推荐的实用程序。结论:韩国初级医生普遍对实用指南持积极态度,因为指南在初级医生中的传播可以提高指南的依从性和患者对GB息肉的护理。
{"title":"A survey of attitudes to clinical practice guidelines in general and adherence of the Korea practical guidelines for management of gallbladder polyp: a survey among private clinicians in Korea.","authors":"Jooyeon Jeong,&nbsp;Jae Keun Kim,&nbsp;Joon Seong Park,&nbsp;Dong Sup Yoon","doi":"10.14701/kjhbps.2014.18.2.52","DOIUrl":"https://doi.org/10.14701/kjhbps.2014.18.2.52","url":null,"abstract":"<p><strong>Backgrounds/aims: </strong>While clinical practice guidelines are effective tools for improving the quality of patient care and provide specific recommendations for daily practice, the usage of them have been often suboptimal. Therefore, evaluation of physician attitude to guidelines is an important initial step in improving guideline adherence levels. The aim of this study was to survey the attitude on general guidelines and adherence with the Korea Practical Guidelines for gallbladder (GB) polyp two year after their publication and distribution among Korean private clinicians.</p><p><strong>Methods: </strong>To evaluate the survey, questionnaires were sent with a stamp on an addressed envelope to 3,256 private clinicians who were registered at the Seoul Medical Association in April, 2010. From the 3,256 questionnaires, 376 clinicians (11.5%) responded to the survey.</p><p><strong>Results: </strong>A total of 91.0% responders agreed to the statement that general guidelines were useful tools for improving patient care and quality of care. One hundred one responders (26.9%) stated that they were aware of the Korea GB polyp guidelines while 73 physicians (72.3%) founded the guideline had changed their practice and user-friendly. Most of physicians (73.4%) agreed to practical procedures recommended by guidelines.</p><p><strong>Conclusions: </strong>Korean primary physicians were generally positive to the practical guidelines, as propagation of the guideline among primary physicians may improve adherence to guideline and patients care for GB polyps.</p>","PeriodicalId":91136,"journal":{"name":"Korean journal of hepato-biliary-pancreatic surgery","volume":"18 2","pages":"52-5"},"PeriodicalIF":0.0,"publicationDate":"2014-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.14701/kjhbps.2014.18.2.52","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33887493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Impact of critical pathway implementation on hospital stay and costs in patients undergoing pancreaticoduodenectomy. 实施关键通路对胰十二指肠切除术患者住院时间和费用的影响。
Pub Date : 2014-02-01 Epub Date: 2014-02-24 DOI: 10.14701/kjhbps.2014.18.1.14
Hyoung-Eun Kim, Young Hoon Kim, Ki Byung Song, Young Soo Chung, Shin Hwang, Young Ju Lee, Kwang Min Park, Song-Cheol Kim

Backgrounds/aims: Recent studies have shown that pancreaticoduodenectomy (PD) can be performed quite safely. Critical pathway (CP) has been one of the key tools used to achieve excellent outcomes in high-quality, high-volume centers. This study was designed to evaluate the impact of CP implementation for PD patients.

Methods: The important components of CP for PD patients include the early start of an oral diet and removal of the abdomen drain following follow-up computed tomography, with the intention of shortening the postoperative hospital stay. The study group (CP group) comprised of 88 patients who underwent pylorus-preserving or classical PD from January 2009 to December 2010. The control group (pre-CP group) was 185 patients who underwent PD between January 2005 and December 2008.

Results: The two groups did not show significant differences in demographic profiles and the primary diagnosis. The incidences of overall postoperative complications such as delayed gastric emptying, fistula, and hemorrhage were similar or decreased in the CP group (54% vs. 40.9%). The incidence of clinically significant complications also showed a similar rate (5.4% vs. 4.5%) between the two groups. The nutritional status at discharge and re-admission rates were not different. The CP group showed a significantly shorter postoperative hospital stay (20.2±9.2 days vs. 14.9±5.1 days, p<0.001) and the total medical costs were also significantly reduced, by 15% (p<0.001).

Conclusions: The results of this study indicated that the implementation of CP for PD patients can decrease the length of hospital stay and reduce medial costs, with maintenance or improvement of patient outcomes. Further investigation is necessary to validate the actual impact of CP for PD through multi-center high-volume studies.

背景/目的:近年来的研究表明,胰十二指肠切除术(PD)可以相当安全地进行。在高质量、高容量的中心,关键通路(CP)一直是获得优异结果的关键工具之一。本研究旨在评估CP实施对PD患者的影响。方法:PD患者CP的重要组成部分包括早期开始口服饮食和随访计算机断层扫描后清除腹部引流管,目的是缩短术后住院时间。研究小组(CP组)由2009年1月至2010年12月期间接受幽门保留或经典PD治疗的88例患者组成。对照组(cp前组)为185例2005年1月至2008年12月间接受PD治疗的患者。结果:两组在人口学特征和初诊方面无显著差异。CP组总体术后并发症如胃排空延迟、瘘管和出血的发生率相似或降低(54%对40.9%)。两组临床显著并发症发生率相似(5.4% vs. 4.5%)。出院时营养状况和再入院率无差异。CP组术后住院时间明显缩短(20.2±9.2天vs. 14.9±5.1天)。结论:本研究结果表明,对PD患者实施CP可缩短住院时间,降低医疗费用,维持或改善患者预后。需要通过多中心大容量研究来验证CP对PD的实际影响。
{"title":"Impact of critical pathway implementation on hospital stay and costs in patients undergoing pancreaticoduodenectomy.","authors":"Hyoung-Eun Kim,&nbsp;Young Hoon Kim,&nbsp;Ki Byung Song,&nbsp;Young Soo Chung,&nbsp;Shin Hwang,&nbsp;Young Ju Lee,&nbsp;Kwang Min Park,&nbsp;Song-Cheol Kim","doi":"10.14701/kjhbps.2014.18.1.14","DOIUrl":"https://doi.org/10.14701/kjhbps.2014.18.1.14","url":null,"abstract":"<p><strong>Backgrounds/aims: </strong>Recent studies have shown that pancreaticoduodenectomy (PD) can be performed quite safely. Critical pathway (CP) has been one of the key tools used to achieve excellent outcomes in high-quality, high-volume centers. This study was designed to evaluate the impact of CP implementation for PD patients.</p><p><strong>Methods: </strong>The important components of CP for PD patients include the early start of an oral diet and removal of the abdomen drain following follow-up computed tomography, with the intention of shortening the postoperative hospital stay. The study group (CP group) comprised of 88 patients who underwent pylorus-preserving or classical PD from January 2009 to December 2010. The control group (pre-CP group) was 185 patients who underwent PD between January 2005 and December 2008.</p><p><strong>Results: </strong>The two groups did not show significant differences in demographic profiles and the primary diagnosis. The incidences of overall postoperative complications such as delayed gastric emptying, fistula, and hemorrhage were similar or decreased in the CP group (54% vs. 40.9%). The incidence of clinically significant complications also showed a similar rate (5.4% vs. 4.5%) between the two groups. The nutritional status at discharge and re-admission rates were not different. The CP group showed a significantly shorter postoperative hospital stay (20.2±9.2 days vs. 14.9±5.1 days, p<0.001) and the total medical costs were also significantly reduced, by 15% (p<0.001).</p><p><strong>Conclusions: </strong>The results of this study indicated that the implementation of CP for PD patients can decrease the length of hospital stay and reduce medial costs, with maintenance or improvement of patient outcomes. Further investigation is necessary to validate the actual impact of CP for PD through multi-center high-volume studies.</p>","PeriodicalId":91136,"journal":{"name":"Korean journal of hepato-biliary-pancreatic surgery","volume":"18 1","pages":"14-20"},"PeriodicalIF":0.0,"publicationDate":"2014-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.14701/kjhbps.2014.18.1.14","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33991005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Systemic capillary leak syndrome (Clarkson's disease) during elective pylorus-preserving pancreaticoduodenectomy: case report. 选择性保幽门胰十二指肠切除术中系统性毛细血管渗漏综合征(克拉克森病)1例。
Pub Date : 2014-02-01 Epub Date: 2014-02-24 DOI: 10.14701/kjhbps.2014.18.1.38
Kun Moo Choi, Cheon Soo Park, Mi Hye Kim

Systemic capillary leak syndrome (SCLS), also called Clarkson's disease is rare and life-threatening disorder of unknown etiology, which is a characteristic triad of hypovolemic shock, hemoconcentration, and hypoalbuminemia. Unexplained capillary leakage from the intravascular to the interstitial space, which has been estimated up to 70% of the intravascular volume, is the proposed mechanism. Because the pathogenesis is unknown, it is diagnosed clinically after exclusion of other diseases that cause systemic capillary leak and no efficacious pharmacological treatment has been clearly established. The mortality rate ranges from 30% to 76%. In Korea, four cases of SCLS (5 cases in adult and 1 case in child) were reported by 2012. We describe a case of severe SCLS that suddenly occurred and rapidly progressed during pylorus preserving pancreaticoduodenectomy and review the literature.

系统性毛细血管渗漏综合征(SCLS),也称为克拉克森病,是一种罕见的、病因不明的危及生命的疾病,是低血容量性休克、血浓缩和低白蛋白血症的特征性三重征。原因不明的毛细血管渗漏从血管内到间隙,估计占血管内体积的70%,是提出的机制。由于发病机制不明,在排除其他引起全身性毛细血管渗漏的疾病后,临床上才确诊,并无明确的有效药物治疗。死亡率从30%到76%不等。截至2012年,韩国共报告了4例scs(成人5例,儿童1例)。我们描述了一个严重的scs,突然发生并迅速发展在保留幽门胰十二指肠切除术和回顾文献。
{"title":"Systemic capillary leak syndrome (Clarkson's disease) during elective pylorus-preserving pancreaticoduodenectomy: case report.","authors":"Kun Moo Choi,&nbsp;Cheon Soo Park,&nbsp;Mi Hye Kim","doi":"10.14701/kjhbps.2014.18.1.38","DOIUrl":"https://doi.org/10.14701/kjhbps.2014.18.1.38","url":null,"abstract":"<p><p>Systemic capillary leak syndrome (SCLS), also called Clarkson's disease is rare and life-threatening disorder of unknown etiology, which is a characteristic triad of hypovolemic shock, hemoconcentration, and hypoalbuminemia. Unexplained capillary leakage from the intravascular to the interstitial space, which has been estimated up to 70% of the intravascular volume, is the proposed mechanism. Because the pathogenesis is unknown, it is diagnosed clinically after exclusion of other diseases that cause systemic capillary leak and no efficacious pharmacological treatment has been clearly established. The mortality rate ranges from 30% to 76%. In Korea, four cases of SCLS (5 cases in adult and 1 case in child) were reported by 2012. We describe a case of severe SCLS that suddenly occurred and rapidly progressed during pylorus preserving pancreaticoduodenectomy and review the literature. </p>","PeriodicalId":91136,"journal":{"name":"Korean journal of hepato-biliary-pancreatic surgery","volume":"18 1","pages":"38-41"},"PeriodicalIF":0.0,"publicationDate":"2014-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.14701/kjhbps.2014.18.1.38","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33991010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
A comparative study regarding the effect of an intraperitoneal anti-adhesive agent application in left-liver living donors. 一种抗粘剂腹腔内应用于左肝活体供体的效果比较研究。
Pub Date : 2014-02-01 Epub Date: 2014-02-24 DOI: 10.14701/kjhbps.2014.18.1.26
Cheon-Soo Park, Shin Hwang, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park, Hyung-Woo Park, Yo-Han Park, Sung-Hwa Kang, Bo-Hyun Jung, Sung-Gyu Lee

Backgrounds/aims: After left-sided hepatectomy due to a living donor, the stomach can become adhered to the hepatic cut surface. An unwanted gastric stasis can occur. For prevention of such gastric adhesion and laparotomy-associated adhesive ileus, some anti-adhesive agents have been developed for intra-abdominal application. The purpose of this study is to evaluate the effect of an intraperitoneal anti-adhesive agent application compared with a historical control group.

Methods: The study group consisted of 220 consecutive living donors who donated a left-liver graft during the time period between January 2006 and December 2011. The anti-adhesive agent which was used was composed of sodium hyaluronate and sodium carboxymethyl cellulose. The historical control group which used no anti-adhesive agent included 220 consecutive left-liver donors during the time period between January 1998 and December 2004.

Results: An overt gastric stasis which required fasting was observed in 5 subjects (2.3%) in the study group and in 7 subjects (3.2%) in the control group (p=0.77). An additional work-up to determine gastric stasis or prolonged ileus was performed in 17 (7.7%) and 22 (10%) donors, respectively (p=0.51). Only one donor in the control group underwent a laparotomy for an intestinal obstruction. No clinical factors such as patient age, sex, body mass index, remnant right liver proportion, shape of skin incision, and duration of surgery were significant risk factors of gastric stasis or prolonged ileus. No harmful side-effects of the anti-adhesive agent were identified.

Conclusions: As a result of this study, the application of an anti-adhesive agent could not be proved as to be effective for prevention of gastric stasis and postoperative ileus. A further randomized and controlled study will be required to demonstrate the real benefits of an anti-adhesive application in left-liver living donors.

背景/目的:活体供体左肝切除术后,胃可与肝脏切面粘连。可能会出现不想要的胃淤滞。为了预防这种胃粘连和开腹相关的粘连性肠梗阻,一些抗粘连剂被开发用于腹腔内应用。本研究的目的是评价腹腔抗粘剂应用的效果,并与历史对照组进行比较。方法:研究组由2006年1月至2011年12月期间连续捐赠左肝移植的220例活体供体组成。所采用的抗粘剂由透明质酸钠和羧甲基纤维素钠组成。历史对照组为1998年1月至2004年12月连续220例左肝供体,不使用抗粘剂。结果:研究组5例(2.3%)和对照组7例(3.2%)出现明显的胃淤滞,需要禁食(p=0.77)。分别有17例(7.7%)和22例(10%)供体进行了额外的检查以确定胃淤积或延长的肠梗阻(p=0.51)。对照组中只有一名供体因肠梗阻进行了剖腹手术。患者年龄、性别、体重指数、残右肝比例、皮肤切口形状、手术时间等临床因素均不是胃淤积或延长性肠梗阻的显著危险因素。未发现该抗粘剂的有害副作用。结论:本研究结果不能证明抗粘剂的应用对预防胃瘀和术后肠梗阻有效。需要进一步的随机对照研究来证明抗黏附应用于左肝活体供者的真正益处。
{"title":"A comparative study regarding the effect of an intraperitoneal anti-adhesive agent application in left-liver living donors.","authors":"Cheon-Soo Park,&nbsp;Shin Hwang,&nbsp;Chul-Soo Ahn,&nbsp;Ki-Hun Kim,&nbsp;Deok-Bog Moon,&nbsp;Tae-Yong Ha,&nbsp;Gi-Won Song,&nbsp;Dong-Hwan Jung,&nbsp;Gil-Chun Park,&nbsp;Hyung-Woo Park,&nbsp;Yo-Han Park,&nbsp;Sung-Hwa Kang,&nbsp;Bo-Hyun Jung,&nbsp;Sung-Gyu Lee","doi":"10.14701/kjhbps.2014.18.1.26","DOIUrl":"https://doi.org/10.14701/kjhbps.2014.18.1.26","url":null,"abstract":"<p><strong>Backgrounds/aims: </strong>After left-sided hepatectomy due to a living donor, the stomach can become adhered to the hepatic cut surface. An unwanted gastric stasis can occur. For prevention of such gastric adhesion and laparotomy-associated adhesive ileus, some anti-adhesive agents have been developed for intra-abdominal application. The purpose of this study is to evaluate the effect of an intraperitoneal anti-adhesive agent application compared with a historical control group.</p><p><strong>Methods: </strong>The study group consisted of 220 consecutive living donors who donated a left-liver graft during the time period between January 2006 and December 2011. The anti-adhesive agent which was used was composed of sodium hyaluronate and sodium carboxymethyl cellulose. The historical control group which used no anti-adhesive agent included 220 consecutive left-liver donors during the time period between January 1998 and December 2004.</p><p><strong>Results: </strong>An overt gastric stasis which required fasting was observed in 5 subjects (2.3%) in the study group and in 7 subjects (3.2%) in the control group (p=0.77). An additional work-up to determine gastric stasis or prolonged ileus was performed in 17 (7.7%) and 22 (10%) donors, respectively (p=0.51). Only one donor in the control group underwent a laparotomy for an intestinal obstruction. No clinical factors such as patient age, sex, body mass index, remnant right liver proportion, shape of skin incision, and duration of surgery were significant risk factors of gastric stasis or prolonged ileus. No harmful side-effects of the anti-adhesive agent were identified.</p><p><strong>Conclusions: </strong>As a result of this study, the application of an anti-adhesive agent could not be proved as to be effective for prevention of gastric stasis and postoperative ileus. A further randomized and controlled study will be required to demonstrate the real benefits of an anti-adhesive application in left-liver living donors.</p>","PeriodicalId":91136,"journal":{"name":"Korean journal of hepato-biliary-pancreatic surgery","volume":"18 1","pages":"26-8"},"PeriodicalIF":0.0,"publicationDate":"2014-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.14701/kjhbps.2014.18.1.26","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33991007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
AFP-producing acinar cell carcinoma treated by pancreaticoduodenectomy in a patient with a previous radical subtotal gastrectomy by gastric cancer. 胰十二指肠切除术治疗因胃癌行根治性胃次全切除术患者的产afp腺泡细胞癌。
Pub Date : 2014-02-01 Epub Date: 2014-02-24 DOI: 10.14701/kjhbps.2014.18.1.33
Chang Young Kim, Sung Hwan Lee, Hyae Min Jeon, Hyun Ki Kim, Chang Moo Kang, Woo Jung Lee

We report a case of alpha-fetoprotein (AFP)-producing acinar cell carcinoma (ACC) of the pancreas. The tumor was diagnosed in a 72 yearold female after radical subtotal gastrectomy (Billroth I) due to early gastric cancer six months before. The initial serum AFP levels were increased to 2,254.1 IU/ml and preoperative imaging studies showed a mass with approximately 2.5 cm in diameter near the neck of the pancreas. A pancreaticoduodenectomy was performed. The pathologic examination revealed an ill-defined lobulating tumor confined to the pancreas (T1 stage). Immunohistochemical study showed that the tumor cells expressed AFP. The Adenosine triphosphate-based chemotherapy response assay (ATP-CRA) suggested that cisplatin would be more desirable than gemcitabine in AFP-producing ACC of the pancreas as an adjuvant chemotherapy. However, the adjuvant chemotherapy was not performed due to the early pathological stage. The patient died from carcinomatosis and pneumonia. Even if the tumor was on a relatively early stage, an adjuvant treatment should be considered ACC.

我们报告一例甲胎蛋白(AFP)产生腺泡细胞癌(ACC)的胰腺。此肿瘤是一位72岁的女性,于6个月前因早期胃癌行根治性胃次全切除术(Billroth I)后被诊断出来。初始血清AFP水平升高至2254.1 IU/ml,术前影像学检查显示胰腺颈部附近有一个直径约2.5 cm的肿块。行胰十二指肠切除术。病理检查显示一界限不清的分叶状肿瘤局限于胰腺(T1期)。免疫组化研究显示肿瘤细胞表达AFP。基于三磷酸腺苷的化疗反应测定(ATP-CRA)表明,顺铂作为辅助化疗在胰腺产生afp的ACC中比吉西他滨更可取。但因病理阶段较早,未行辅助化疗。病人死于癌病和肺炎。即使肿瘤处于相对早期,也应考虑辅助治疗。
{"title":"AFP-producing acinar cell carcinoma treated by pancreaticoduodenectomy in a patient with a previous radical subtotal gastrectomy by gastric cancer.","authors":"Chang Young Kim,&nbsp;Sung Hwan Lee,&nbsp;Hyae Min Jeon,&nbsp;Hyun Ki Kim,&nbsp;Chang Moo Kang,&nbsp;Woo Jung Lee","doi":"10.14701/kjhbps.2014.18.1.33","DOIUrl":"https://doi.org/10.14701/kjhbps.2014.18.1.33","url":null,"abstract":"<p><p>We report a case of alpha-fetoprotein (AFP)-producing acinar cell carcinoma (ACC) of the pancreas. The tumor was diagnosed in a 72 yearold female after radical subtotal gastrectomy (Billroth I) due to early gastric cancer six months before. The initial serum AFP levels were increased to 2,254.1 IU/ml and preoperative imaging studies showed a mass with approximately 2.5 cm in diameter near the neck of the pancreas. A pancreaticoduodenectomy was performed. The pathologic examination revealed an ill-defined lobulating tumor confined to the pancreas (T1 stage). Immunohistochemical study showed that the tumor cells expressed AFP. The Adenosine triphosphate-based chemotherapy response assay (ATP-CRA) suggested that cisplatin would be more desirable than gemcitabine in AFP-producing ACC of the pancreas as an adjuvant chemotherapy. However, the adjuvant chemotherapy was not performed due to the early pathological stage. The patient died from carcinomatosis and pneumonia. Even if the tumor was on a relatively early stage, an adjuvant treatment should be considered ACC. </p>","PeriodicalId":91136,"journal":{"name":"Korean journal of hepato-biliary-pancreatic surgery","volume":"18 1","pages":"33-7"},"PeriodicalIF":0.0,"publicationDate":"2014-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.14701/kjhbps.2014.18.1.33","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33991009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Clinical features and survival outcome of locally advanced extrahepatic cholangiocarcinoma. 局部晚期肝外胆管癌的临床特点及生存结局。
Pub Date : 2014-02-01 Epub Date: 2014-02-24 DOI: 10.14701/kjhbps.2014.18.1.1
Sang-Jae Lee, Wooil Kwon, Mee Joo Kang, Jin-Young Jang, Ye Rim Chang, Woohyun Jung, Sun-Whe Kim

Backgrounds/aims: Little is known about clinical features and survival outcome in locally advanced unresectable extrahepatic cholangiocarcinoma (EHC). The aim was to investigate the clinical features and the survival outcome in these patients, and to evaluate the role of palliative resections in locally advanced unresectable EHC.

Methods: Between 1995 and 2007, 280 patients with locally advanced unresectable EHC were identified. Clinical, pathologic, and survival data were investigated. A comparative analysis was done between those who received palliative resection (PR) and those who were not operated on (NR).

Results: The overall median survival of the study population was 10±1 months, and the 3- and 5-year survival rates (YSR) were 8.5% and 2.5%, respectively. The median survival, 3- and 5-YSR of PR were 23 months, 32.1% and 13.1%, respectively. For NR, they were 9 months, 3.9% and 0%, which were significantly worse than PR (p<0.001). In univariate analysis, T classification, N classification, tumor location, palliative resection, adjuvant treatment, chemotherapy, and radiation therapy were factors that showed survival difference between PR and NR. Regional lymph node metastasis (RR, 2.084; 95% CI, 1.491-2.914; p<0.001), non-resections (RR, 2.270; 95% CI, 1.497-3.443; p<0.001), and no chemotherapy (RR, 1.604; 95% CI, 1.095-2.349; p=0.015) were identified as risk factors for poor outcome on multivariate analysis.

Conclusions: Without evidence of systemic disease, palliative resection may provide some survival benefit in selected locally advanced unresectable EHCs and adjuvant treatment may further improve survival outcome.

背景/目的:局部晚期不可切除肝外胆管癌(EHC)的临床特征和生存结局尚不清楚。目的是研究这些患者的临床特征和生存结果,并评估姑息性切除术在局部晚期不可切除的EHC中的作用。方法:1995 ~ 2007年间,对280例局部晚期不可切除的EHC患者进行了回顾性分析。研究了临床、病理和生存数据。对姑息性切除(PR)组与未行姑息性切除(NR)组进行比较分析。结果:研究人群的总中位生存期为10±1个月,3年和5年生存率(YSR)分别为8.5%和2.5%。PR的中位生存期为23个月,3- ysr为32.1%,5-YSR为13.1%。NR分别为9个月、3.9%和0%,明显差于PR (p结论:在没有全身性疾病证据的情况下,姑息性切除可能对部分局部晚期不可切除的EHCs提供一定的生存益处,辅助治疗可能进一步改善生存结果。
{"title":"Clinical features and survival outcome of locally advanced extrahepatic cholangiocarcinoma.","authors":"Sang-Jae Lee,&nbsp;Wooil Kwon,&nbsp;Mee Joo Kang,&nbsp;Jin-Young Jang,&nbsp;Ye Rim Chang,&nbsp;Woohyun Jung,&nbsp;Sun-Whe Kim","doi":"10.14701/kjhbps.2014.18.1.1","DOIUrl":"https://doi.org/10.14701/kjhbps.2014.18.1.1","url":null,"abstract":"<p><strong>Backgrounds/aims: </strong>Little is known about clinical features and survival outcome in locally advanced unresectable extrahepatic cholangiocarcinoma (EHC). The aim was to investigate the clinical features and the survival outcome in these patients, and to evaluate the role of palliative resections in locally advanced unresectable EHC.</p><p><strong>Methods: </strong>Between 1995 and 2007, 280 patients with locally advanced unresectable EHC were identified. Clinical, pathologic, and survival data were investigated. A comparative analysis was done between those who received palliative resection (PR) and those who were not operated on (NR).</p><p><strong>Results: </strong>The overall median survival of the study population was 10±1 months, and the 3- and 5-year survival rates (YSR) were 8.5% and 2.5%, respectively. The median survival, 3- and 5-YSR of PR were 23 months, 32.1% and 13.1%, respectively. For NR, they were 9 months, 3.9% and 0%, which were significantly worse than PR (p<0.001). In univariate analysis, T classification, N classification, tumor location, palliative resection, adjuvant treatment, chemotherapy, and radiation therapy were factors that showed survival difference between PR and NR. Regional lymph node metastasis (RR, 2.084; 95% CI, 1.491-2.914; p<0.001), non-resections (RR, 2.270; 95% CI, 1.497-3.443; p<0.001), and no chemotherapy (RR, 1.604; 95% CI, 1.095-2.349; p=0.015) were identified as risk factors for poor outcome on multivariate analysis.</p><p><strong>Conclusions: </strong>Without evidence of systemic disease, palliative resection may provide some survival benefit in selected locally advanced unresectable EHCs and adjuvant treatment may further improve survival outcome.</p>","PeriodicalId":91136,"journal":{"name":"Korean journal of hepato-biliary-pancreatic surgery","volume":"18 1","pages":"1-8"},"PeriodicalIF":0.0,"publicationDate":"2014-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/13/70/kjhbps-18-1.PMC4492336.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33991003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Analysis of gallbladder polypoid lesion size as an indication of the risk of gallbladder cancer. 胆囊息肉样病变大小作为胆囊癌危险指标的分析。
Pub Date : 2014-02-01 Epub Date: 2014-02-24 DOI: 10.14701/kjhbps.2014.18.1.9
Ji Eun Sung, Chang Woo Nam, Yang Won Nah, Byung Sung Kim

Backgrounds/aims: Recent advances in ultrasonography have contributed to the early detection of gallbladder cancer. We attempted to predict the progression of the disease by comparing the sizes of polypoid lesions, and we suggest that the size of the lesion would be a useful guideline to determine an appropriate primary surgical approach for polypoid lesions of the gallbladder.

Methods: We have retrospectively analyzed 253 patients that, during the operation period from January 2009 to December 2011, had had ultrasonographically detected gallbladder polypoid lesions, and who underwent cholecystectomy at Ulsan university hospital. We have analyzed the demographic data of the patients, the preoperative size of polypoid lesions, and pathologic findings.

Results: Of a total of 253 patients, 235 patients had benign lesions, and 18 patients had malignant lesions. Among the malignant polyp patients, 11 had pT1 cancer, 6 had pT2 cancer, and 1 had pT3 cancer. The average size of polypoid lesions was 9.1±3.1 mm and that of malignant lesions was 28.2±16.4 mm. The receiver operating characteristic (ROC) curve of the benign and malignant groups shows that 14.5 mm is the optimal point of prediction of the malignancy. Of a total of 18 patients of GB cancer, 11 had pT1 and the average size of their polypoid lesions was 20.5±5.8 mm 7 had pT2 with a size of 39.1±20.7 mm. ROC curve analysis of the pT1 and pT2 groups shows that 27 mm would be the optimal point to predict T2 and above cancer.

Conclusions: In the case of an early cancer, curative treatment can be achieved through a simple and minimally invasive laparoscopic cholecystectomy. We attempted to predict early cancer occurrence among polypoid lesions of the gallbladder using the simplest standard, size. Although there are some limitations, size can be a simple and easy way to evaluate polypoid lesions of the gallbladder.

背景/目的:超声检查的最新进展有助于胆囊癌的早期发现。我们试图通过比较息肉样病变的大小来预测疾病的进展,我们建议病变的大小将是一个有用的指导方针,以确定胆囊息肉样病变的合适的初级手术入路。方法:回顾性分析2009年1月至2011年12月在蔚山大学医院行胆囊切除术的超声检查发现胆囊息肉样病变的253例患者。我们分析了患者的人口统计资料,术前息肉病变的大小和病理结果。结果:253例患者中,良性病变235例,恶性病变18例。恶性息肉患者中pT1癌11例,pT2癌6例,pT3癌1例。息肉样病变平均大小为9.1±3.1 mm,恶性病变平均大小为28.2±16.4 mm。良恶性组的受试者工作特征(ROC)曲线显示,14.5 mm为预测恶性的最佳点。18例GB癌患者中,ptt1 11例,息肉样病变平均大小20.5±5.8 mm, pT2 7例,平均大小39.1±20.7 mm。pT1和pT2组的ROC曲线分析显示,27 mm为预测T2及以上肿瘤的最佳点。结论:在早期癌症的情况下,通过简单的微创腹腔镜胆囊切除术可以实现根治性治疗。我们试图用最简单的标准——大小来预测胆囊息肉样病变的早期癌症发生。虽然有一些限制,大小可以是一个简单和容易的方法来评估胆囊息肉病变。
{"title":"Analysis of gallbladder polypoid lesion size as an indication of the risk of gallbladder cancer.","authors":"Ji Eun Sung,&nbsp;Chang Woo Nam,&nbsp;Yang Won Nah,&nbsp;Byung Sung Kim","doi":"10.14701/kjhbps.2014.18.1.9","DOIUrl":"https://doi.org/10.14701/kjhbps.2014.18.1.9","url":null,"abstract":"<p><strong>Backgrounds/aims: </strong>Recent advances in ultrasonography have contributed to the early detection of gallbladder cancer. We attempted to predict the progression of the disease by comparing the sizes of polypoid lesions, and we suggest that the size of the lesion would be a useful guideline to determine an appropriate primary surgical approach for polypoid lesions of the gallbladder.</p><p><strong>Methods: </strong>We have retrospectively analyzed 253 patients that, during the operation period from January 2009 to December 2011, had had ultrasonographically detected gallbladder polypoid lesions, and who underwent cholecystectomy at Ulsan university hospital. We have analyzed the demographic data of the patients, the preoperative size of polypoid lesions, and pathologic findings.</p><p><strong>Results: </strong>Of a total of 253 patients, 235 patients had benign lesions, and 18 patients had malignant lesions. Among the malignant polyp patients, 11 had pT1 cancer, 6 had pT2 cancer, and 1 had pT3 cancer. The average size of polypoid lesions was 9.1±3.1 mm and that of malignant lesions was 28.2±16.4 mm. The receiver operating characteristic (ROC) curve of the benign and malignant groups shows that 14.5 mm is the optimal point of prediction of the malignancy. Of a total of 18 patients of GB cancer, 11 had pT1 and the average size of their polypoid lesions was 20.5±5.8 mm 7 had pT2 with a size of 39.1±20.7 mm. ROC curve analysis of the pT1 and pT2 groups shows that 27 mm would be the optimal point to predict T2 and above cancer.</p><p><strong>Conclusions: </strong>In the case of an early cancer, curative treatment can be achieved through a simple and minimally invasive laparoscopic cholecystectomy. We attempted to predict early cancer occurrence among polypoid lesions of the gallbladder using the simplest standard, size. Although there are some limitations, size can be a simple and easy way to evaluate polypoid lesions of the gallbladder.</p>","PeriodicalId":91136,"journal":{"name":"Korean journal of hepato-biliary-pancreatic surgery","volume":"18 1","pages":"9-13"},"PeriodicalIF":0.0,"publicationDate":"2014-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.14701/kjhbps.2014.18.1.9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33991004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Preliminary results of binding pancreaticojejunostomy. 胰空肠吻合术的初步结果。
Pub Date : 2014-02-01 Epub Date: 2014-02-24 DOI: 10.14701/kjhbps.2014.18.1.21
Jin Min Kim, Jung Bum Hong, Woo Young Shin, Yun-Mee Choe, Gun Young Lee, Seung Ik Ahn

Backgrounds/aims: The post-operative complications and clinical course of pancreaticoduodenectomy (PD) largely depend on the pancreaticojejunostomy (PJ). Several methods of PJ are in clinical use. We analyzed the early results of binding pancreaticojejunostomy (BPJ), a technique reported by SY Peng.

Methods: We retrospectively reviewed the clinical results of patients who received BPJ in Inha University Hospital from 2006 to 2011. 21 BPJs were performed with Peng's method. The definition of postoperative pancreatic fistula (PF) was a high amylase content (>3 times the upper normal serum value) of the drain fluid (of any measurable volume), at any time on or after the 3rd post-operative day. The pancreatic fistula was graded according to the International Study Group for Pancreatic Fistula (ISGPF) guidelines.

Results: Of the 21 patients who received BPJ, 11 were male. The median age was 61.2 years. PD surgery included 4 cases of Whipple's procedures and 17 cases of pylorus-preserving PD. According to the post-operative course, 16 patients recovered well with no evidence of PF. A total of 5 patients (23.8%), including 3 grade A PFs and 2 grade C PFs, suffered from a pancreatic fistula. 3 patients with grade A PF recovered with conservative management.

Conclusions: The BPJ appears to be a relatively safe procedure based on this preliminary study, but further study is needed to validate its safety.

背景/目的:胰十二指肠切除术(PD)的术后并发症和临床病程在很大程度上取决于胰空肠吻合术(PJ)。临床应用了几种PJ方法。我们分析了结合胰空肠吻合术(BPJ)的早期结果,这是一种由SY Peng报道的技术。方法:回顾性分析2006 ~ 2011年在仁荷大学医院接受BPJ治疗的患者的临床结果。21例BPJs采用Peng的方法。术后胰瘘(PF)的定义是在术后第3天或之后的任何时间(任何可测量容积)引流液中淀粉酶含量高(>正常血清上值的3倍)。根据国际胰瘘研究小组(ISGPF)指南对胰瘘进行分级。结果:接受BPJ治疗的21例患者中,男性11例。中位年龄为61.2岁。PD手术包括4例Whipple手术和17例保幽门PD。16例患者术后恢复良好,无PF迹象,5例(23.8%)患者出现胰瘘,其中3例为A级PFs, 2例为C级PFs。3例A级PF患者经保守治疗痊愈。结论:根据这项初步研究,BPJ似乎是一种相对安全的手术,但需要进一步的研究来验证其安全性。
{"title":"Preliminary results of binding pancreaticojejunostomy.","authors":"Jin Min Kim,&nbsp;Jung Bum Hong,&nbsp;Woo Young Shin,&nbsp;Yun-Mee Choe,&nbsp;Gun Young Lee,&nbsp;Seung Ik Ahn","doi":"10.14701/kjhbps.2014.18.1.21","DOIUrl":"https://doi.org/10.14701/kjhbps.2014.18.1.21","url":null,"abstract":"<p><strong>Backgrounds/aims: </strong>The post-operative complications and clinical course of pancreaticoduodenectomy (PD) largely depend on the pancreaticojejunostomy (PJ). Several methods of PJ are in clinical use. We analyzed the early results of binding pancreaticojejunostomy (BPJ), a technique reported by SY Peng.</p><p><strong>Methods: </strong>We retrospectively reviewed the clinical results of patients who received BPJ in Inha University Hospital from 2006 to 2011. 21 BPJs were performed with Peng's method. The definition of postoperative pancreatic fistula (PF) was a high amylase content (>3 times the upper normal serum value) of the drain fluid (of any measurable volume), at any time on or after the 3rd post-operative day. The pancreatic fistula was graded according to the International Study Group for Pancreatic Fistula (ISGPF) guidelines.</p><p><strong>Results: </strong>Of the 21 patients who received BPJ, 11 were male. The median age was 61.2 years. PD surgery included 4 cases of Whipple's procedures and 17 cases of pylorus-preserving PD. According to the post-operative course, 16 patients recovered well with no evidence of PF. A total of 5 patients (23.8%), including 3 grade A PFs and 2 grade C PFs, suffered from a pancreatic fistula. 3 patients with grade A PF recovered with conservative management.</p><p><strong>Conclusions: </strong>The BPJ appears to be a relatively safe procedure based on this preliminary study, but further study is needed to validate its safety.</p>","PeriodicalId":91136,"journal":{"name":"Korean journal of hepato-biliary-pancreatic surgery","volume":"18 1","pages":"21-5"},"PeriodicalIF":0.0,"publicationDate":"2014-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.14701/kjhbps.2014.18.1.21","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33991006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
期刊
Korean journal of hepato-biliary-pancreatic surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1